Acute Myeloid Leukemia - Opportunity Analysis and Forecasts to 2029

Sakis Paliouras, PhD, is a Managing Oncology and Hematology Analyst at GlobalData in New York. He specializes in data-driven business intelligence in the oncology pharmaceutical market particularly in blood malignancies, in the field of immuno-oncology, and using quantitative approaches for data analysis. Sakis produces and manages syndicated reports directly and is experienced in helping clients in both syndicated and consulting projects. Before joining GlobalData, Sakis graduated with a BSc in Molecular Biology and Genetics from the Democritus University of Thrace (DUTH). He greatly enjoys coding and has also run a small freelancing business. He then received a Cancer Research UK-funded PhD in Cancer Medicine from the Cancer Research UK Manchester Institute, University of Manchester. His research focused on the identification of mechanisms of resistance to targeted therapies in lung cancer. Sakis is passionate about biomarker-driven development in oncology as well as therapies with novel mechanisms of action.

Fern Barkalow, PhD, is the Senior Director of Oncology and Hematology at GlobalData in Boston. Fern has over 20 years of experience in the biopharmaceutical industry, as well as a research background in molecular mechanisms of inflammation and metastasis. After leaving the lab bench, Fern then joined the database group at Incyte Pharmaceuticals where she helped develop the Proteome BioKnowledge Library, and led a cross-functional team tasked with creating databases covering diseases and molecular interactions. She then moved into the Medical Affairs group at Millennium Pharmaceuticals and managed medical writing projects involving clinical trials results for oncology drugs. Most recently, Fern was Associate Director of the Oncology team at Citeline, where she participated in developing and managing the Trialtrove database and interacted with clients through the research support service and custom analytics projects. Fern holds a PhD in Microbiology from The University of Medicine and Dentistry of New Jersey and was a postdoctoral fellow in Molecular Biology at Princeton University and in Pathology at Brigham and Women’s Hospital.